Skip to main content

Table 3 Circulating biomarkers

From: Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

 

CAD

No CAD

n = 109

n = 86

 

eGFR ≥60 mL/min

eGFR <60 mL/min

P-value

eGFR ≥60 mL/min

eGFR <60 mL/min

P-value

 

n = 71

n = 38

 

n = 40

n = 46

 

E-selectin (ng/mL)

10.5 [10.4]

17.6 [12.6]

<0.001

10.8 [6.6]

19.2 [14.2]

<0.001

P-selectin (ng/mL)

90.4 [39.0]

106.1 [57.9]

0.015

85.6 [45.9]

113.0 [45.9]

0.001

ICAM-1 (ng/mL)

27.6 [11.4]

34.5 [21.9]

0.002

23.0 [12.6]

33.1 [15.6]

<0.001

VCAM-1 (μg/mL)

1.37 [1.26]

2.03 [1.36]

0.006

0.96 [0.75]

1.42 [0.95]

0.008

sRAGE (ng/mL)

3.8 [2.5]

4.8 [4.7]

0.110

3.8 [3.0]

6.7 [5.9]

<0.001

ENRAGE (ng/mL)

73.2 [81.0]

65.3 [149.9]

0.794

53.9 [56.9]

38.3 [32.2]

0.059

IL-8 (pg/mL)

4.0 [3.7]

3.8 [4.1]

0.218

3.2 [3.0]

5.1 [4.4]

0.005

MCP-1 (pg/mL)

44.6 [31.8]

50.8 [48.1]

0.488

54.9 [40.2]

70.3 [53.7]

0.009

MIP-1β (pg/mL)

66.2 [50.4]

73.5 [56.5]

0.258

66.4 [48.2]

95.0 [91.1]

0.029

CRP (mg/L)

2.0 [2.2]

2.4 [2.9]

0.138

1.3 [1.9]

2.9 [4.8]

<0.001

TNF-α (pg/mL)

0.73 [1.14]

0.96 [1.63]

0.182

0.65 [0.62]

1.73 [1.29]

<0.001

PAI-1(ng/mL)

219.0 [198.6]

152.5 [265.8]

0.329

175.8 [221.0]

153.8 [101.8]

0.044

Adiponectin (μg/mL)

4.1 [3.9]

5.6 [6.9]

0.020

3.5 [4.6]

5.9 [9.3]

0.047

Osteopontin(ng/mL)

0.5 [1.0]

1.8 [4.0]

<0.001

0.0 [0.9]

9.4 [17.9]

<0.001

Leptin (ng/mL)

9.1 [8.0]

15.0 [27.3]

0.011

6.4 [9.0]

16.3 [28.8]

<0.001

  1. CAD coronary artery disease, eGFR estimated glomerular filtration rate, ICAM-1 intercellular adhesion molecule-1, VCAM-1 vascular cell adhesion molecule-1, sRAGE soluble receptor of advanced glycation end-products, ENRAGE extracellular newly identified receptor for advanced glycation end-products binding protein, MCP-1 monocyte chemoattractant protein 1, MIP-1β macrophage inflammatory protein-1 beta, CRP C-reactive protein, TNF-α, tumour necrosis factor alpha, PAI-1 plasminogen activator inhibitor-1. Data are given as median [interquartile range]. P-values refer to comparisons between the eGFR ≥60 mL/min and eGFR <60 mL/min groups.